glp 1 for cardiovascular health The effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1: A Game-Changer for Heart

Redondo A, Trigo MV, Acitores A, Valverde I, Villanueva-Peacarrillo ML

At UAB, scientists are working to understand not just that these medications work, but how they work: how they act in the brain, how they affect multiple organs at once, why some patients respond better than others and what next-generation versions of these drugs might look like

Shima Hadidchi, MD, Family Practice, your health and safety are our top priorities

High-risk individuals may receive more long-term cardiovascular protection if GLP-1 RAs are initiated earlier

Similarly, women who are breastfeeding should avoid NAD+ injections, since it is unknown whether the exogenous NAD+ could affect the nursing infant or alter milk composition

10.1007/s40199-018-0208-2 131 Ould-BrahimF.SarmaS